Showing results (161-170 of 296) with videos related to
Sort By:
Pageof 30
Journal of the Chinese Medical Association : JCMA|May 24, 2015
High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasmsMing-Huang Chen, Ying-Ju Kuo, Yi-Chen Yeh, et al.Journal of Neuro-Oncology|August 21, 2025
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatmentChing-Ying Wang, Chun-Fu Lin, Huai-Che Yang, et al.Oncotarget|June 23, 2014
RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cellsJung-Chen Su, Ping-Hui Tseng, Cheng-Yi Hsu, et al.Breast Cancer (Dove Medical Press)|March 18, 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by ImmunohistochemistryYi-Fang Tsai, Chih-Yi Hsu, Yun-Ning Chiu, et al.BMC Cancer|February 26, 2021
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.Cancer|February 27, 2008
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinomaChun-Yu Liu, Po-Min Chen, Tzeon-Jye Chiou, et al.Molecular Oncology|August 1, 2018
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancerChun-Yu Liu, Chia-Chi Hsu, Tzu-Ting Huang, et al.Neoplasia (New York, N.Y.)|July 23, 2014
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinomaJung-Chen Su, Ping-Hui Tseng, Szu-Hsien Wu, et al.Journal of the Chinese Medical Association : JCMA|March 25, 2015
Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphomaSheng-Hsiang Yang, Liang-Tsai Hsiao, Tzeon-Jye Chiou, et al.The Journal of Clinical Endocrinology and Metabolism|May 12, 2023
The Clinical Benefits of Antiresorptive Agents in Patients with Primary Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysisSheng-Fan Wang, Yi-Sheng Lin, Wan-Yu Yeh, et al.Pageof 30